Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research focused on FOXM1 and Cell growth, with related work in Immunotherapy, Oxaliplatin, Ectopic expression. Notable publications include 'miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1', 'MiR-1271 Inhibits Cell Proliferation, Invasion and EMT in Gastric Cancer by Targeting FOXQ1', and 'The role of circadian genes in predicting immunotherapy response and survival outcomes in cancer patients'.